Repare Therapeutics Inc. (RPTX)
2.650
+0.020 (0.76%)
Inactive · Last trade price on Jan 27, 2026
Repare Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -72.2 | -84.69 | -93.8 | -29.05 | -106.91 | -53.42 |
Depreciation & Amortization | 2.75 | 1.92 | 1.95 | 1.98 | 1.47 | 0.9 |
Loss (Gain) From Sale of Assets | -5.8 | - | - | - | 0.02 | - |
Loss (Gain) From Sale of Investments | -2.35 | -5.16 | -7.47 | -2.23 | 0.11 | - |
Stock-Based Compensation | 12.38 | 23.17 | 25.06 | 19.69 | 12.83 | 2.54 |
Other Operating Activities | -1.15 | 2.37 | 2.27 | 5.53 | -0.32 | 0.2 |
Change in Accounts Receivable | 3 | 2.72 | -0.22 | -1.39 | - | -2.04 |
Change in Accounts Payable | -9.31 | 1.23 | 1.93 | -1.35 | 0.15 | 0.02 |
Change in Unearned Revenue | - | -11.95 | -43.83 | 4.25 | -6.47 | 49.87 |
Change in Income Taxes | 9.76 | 1.53 | -14.33 | 0.72 | 0.51 | -0.2 |
Change in Other Net Operating Assets | -7.57 | -7.58 | 1.26 | 2.17 | 12.81 | -3.94 |
Operating Cash Flow | -70.15 | -76.45 | -127.16 | 0.32 | -85.8 | -6.08 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Capital Expenditures | - | - | -1.94 | -0.6 | -1.69 | -2.24 |
Sale of Property, Plant & Equipment | 1 | - | - | - | 0.04 | - |
Investment in Securities | 61.33 | 49.47 | 79.98 | -175.18 | -0.03 | -7.53 |
Investing Cash Flow | 62.33 | 49.47 | 78.04 | -175.78 | -1.68 | -9.76 |
Financing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Issuance of Common Stock | 0.11 | 0.54 | 0.84 | 0.88 | 95.56 | 232.84 |
Other Financing Activities | - | - | - | - | - | 15 |
Financing Cash Flow | 0.11 | 0.54 | 0.84 | 0.88 | 95.56 | 247.84 |
Net Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Foreign Exchange Rate Adjustments | -0.01 | -0.12 | 0.02 | -0.33 | -0.05 | -0.6 |
Net Cash Flow | -7.72 | -26.55 | -48.25 | -174.91 | 8.03 | 231.39 |
Free Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | -70.15 | -76.45 | -129.1 | -0.28 | -87.49 | -8.32 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -590.97% | -142.95% | -252.47% | -0.21% | -1151.13% | -6163.70% |
Free Cash Flow Per Share | -1.64 | -1.80 | -3.07 | -0.01 | -2.31 | -0.41 |
Levered Free Cash Flow | -42.82 | -44.04 | -97.36 | 51.28 | -28.96 | -35.11 |
Unlevered Free Cash Flow | -42.82 | -44.04 | -97.36 | 51.28 | -28.96 | -35.11 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash Income Tax Paid | - | - | - | 10.81 | 0.03 | 0.16 |
Change in Working Capital | -4.12 | -14.06 | -55.18 | 4.41 | 7 | 43.7 |